WHO demands transparency for fairer drug pricing
Drugmakers are under growing fire as a wave of new treatments for serious conditions like cancer and hepatitis C come to market at sky-high prices, putting them out of reach of many patients and national health services.
May 12, 2017, 09:04 AM IST